UCB-C87032

Study Sponsor : UCB

Study Title

Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).

Medicine or Vaccine (generic name)

Certolizumab Pegol

Sponsor Identification Number

C87032

Trial Registry Identification Number(#'s)

NCT00152425

Medical Condition

Crohn's Disease

Phase

Phase 3

Link to study details on the UCB Clinical Study Register

https://www.ucb.com/clinical-studies/Clinical-studies-index

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/ct2/show/study/NCT00152425?term=NCT00152425&rank=1

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Analysis and Reporting Dataset is AD not ADaM

Datasets are available in English only

Date Added to this Site

July 2014